The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
Geron Quits Stem Cell Research; Move Deemed Setback to the Field

Geron Quits Stem Cell Research; Move Deemed Setback to the Field

David Jensen's avatar
David Jensen
Nov 15, 2011
∙ Paid

Share this post

User's avatar
The California Stem Cell Report
Geron Quits Stem Cell Research; Move Deemed Setback to the Field
Share

In a surprise move, Geron today said it was terminating its stem cell business and what was the first-ever clinical trial of an hESC therapy, a potential product backed by a $25 million loan made by the California stem cell agency only six months ago.

Geron's move has "stark implications" for development of stem cell therapies in the United States, The …

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share